Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 May 4:5:15.
doi: 10.1186/s13756-016-0115-6. eCollection 2016.

Epidemiology and molecular characterization of multidrug-resistant Gram-negative bacteria in Southeast Asia

Affiliations

Epidemiology and molecular characterization of multidrug-resistant Gram-negative bacteria in Southeast Asia

Nuntra Suwantarat et al. Antimicrob Resist Infect Control. .

Abstract

Background: Multidrug-resistant Gram-negative bacteria (MDRGN), including extended-spectrum β-lactamases (ESBLs) and multidrug-resistant glucose-nonfermenting Gram-negative bacilli (nonfermenters), have emerged and spread throughout Southeast Asia.

Methods: We reviewed and summarized current critical knowledge on the epidemiology and molecular characterization of MDRGN in Southeast Asia by PubMed searches for publications prior to 10 March 2016 with the term related to "MDRGN definition" combined with specific Southeast Asian country names (Thailand, Singapore, Malaysia, Vietnam, Indonesia, Philippines, Laos, Cambodia, Myanmar, Brunei).

Results: There were a total of 175 publications from the following countries: Thailand (77), Singapore (35), Malaysia (32), Vietnam (23), Indonesia (6), Philippines (1), Laos (1), and Brunei (1). We did not find any publications on MDRGN from Myanmar and Cambodia. We did not include publications related to Shigella spp., Salmonella spp., and Vibrio spp. and non-human related studies in our review. English language articles and abstracts were included for analysis. After the abstracts were reviewed, data on MDRGN in Southeast Asia from 54 publications were further reviewed and included in this study.

Conclusions: MDRGNs are a major contributor of antimicrobial-resistant bacteria in Southeast Asia. The high prevalence of ESBLs has been a major problem since 2005 and is possibly related to the development of carbapenem resistant organisms in this region due to the overuse of carbapenem therapy. Carbapenem-resistant Acinetobacter baumannii is the most common pathogen associated with nosocomial infections in this region followed by carbapenem-resistant Pseudomonas aeruginosa. Although Southeast Asia is not an endemic area for carbapenem-resistant Enterobacteriaceae (CRE), recently, the rate of CRE detection has been increasing. Limited infection control measures, lack of antimicrobial control, such as the presence of active antimicrobial stewardship teams in the hospital, and outpatient antibiotic restrictions, and travel throughout this region have likely contributed to the increase in MDRGN prevalence.

Keywords: Epidemiology; Gram-negative bacteria; Molecular; Multidrug-resistance; Southeast Asia.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Prevalence (%) of extended-spectrum β-lactamases (ESBLs) and carbapenem-resistant organisms by country in Southeast Asia, adopted from reference 5 (COMPACT II study). The organisms were obtained during April – July 2010, from 5 Centers in Asia-Pacific countries including New Zealand (data not shown), the Philippines (3 centers, 16 A. baumannii isolates, 90 P. aeruginosa isolates, 70 Enterobacteriaceae isolates), Singapore (3 centers, 21 A. baumannii isolates, 120 P. aeruginosa isolates, 96 Enterobacteriaceae isolates), Thailand (10 centers, 59 A. baumannii isolates, 296 P. aeruginosa isolates, 239 Enterobacteriaceae isolates) and Vietnam (3 centers, 19 A. baumannii isolates, 90 P. aeruginosa isolates, 71 Enterobacteriaceae isolates). There are small numbers of A. baumannii isolations tested from reference 5. Prevalence of CRAB in other studies are #70.5-91 % (Singapore) [6, 43, 44], 46.7-80 % (Thailand) [–31] and §more than 90 % (Vietnam) [48]. *Recent studies have been shown the increasing prevalence of CRE in Singapore and Thailand [1, 3, 4, 6, 22]. Abbreviation; CR, carbapenem–resistant; CRE, carbapenem-resistant Enterobacteriaceae; ESBLs, extended-spectrum β-lactamases

References

    1. Mendes RE, Mendoza M, Banga Singh KK, Castanheira M, Bell JM, Turnidge JD, Lin SS, Jones RN. Regional resistance surveillance program results for 12 Asia-Pacific nations (2011) Antimicrob Agents Chemother. 2013;57(11):5721–5726. doi: 10.1128/AAC.01121-13. - DOI - PMC - PubMed
    1. Rice LB. Mechanisms of resistance and clinical relevance of resistance to beta-lactams, glycopeptides, and fluoroquinolones. Mayo Clin Proc. 2012;87(2):198–208. doi: 10.1016/j.mayocp.2011.12.003. - DOI - PMC - PubMed
    1. Tang SS, Apisarnthanarak A, Hsu LY. Mechanisms of β-lactam antimicrobial resistance and epidemiology of major community- and healthcare-associated multidrug-resistant bacteria. Adv Drug Deliv. 2014;78:3–13. doi: 10.1016/j.addr.2014.08.003. - DOI - PubMed
    1. Christiansen KJ, Ip M, Ker HB, Mendoza M, Hsu L, Kiratisin P, et al. In vitro activity of doripenem and other carbapenems against contemporary Gram-negative pathogens isolated from hospitalised patients in the Asia-Pacific region: results of the COMPACT Asia-Pacific Study. Int J Antimicrob Agents. 2010;36(6):501–6. - PubMed
    1. Kiratisin P, Chongthaleong A, Tan TY, Lagamayo E, Roberts S, Garcia J, Davies T. Comparative in vitro activity of carbapenems against major Gram-negative pathogens: results of Asia-Pacific surveillance from the COMPACT II study. Int J Antimicrob Agents. 2012;39(4):311–316. doi: 10.1016/j.ijantimicag.2012.01.002. - DOI - PubMed

LinkOut - more resources